» Articles » PMID: 32719792

The Transcriptional Network That Controls Growth Arrest and Macrophage Differentiation in the Human Myeloid Leukemia Cell Line THP-1

Overview
Specialty Cell Biology
Date 2020 Jul 29
PMID 32719792
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The response of the human acute myeloid leukemia cell line THP-1 to phorbol esters has been widely studied to test candidate leukemia therapies and as a model of cell cycle arrest and monocyte-macrophage differentiation. Here we have employed Cap Analysis of Gene Expression (CAGE) to analyze a dense time course of transcriptional regulation in THP-1 cells treated with phorbol myristate acetate (PMA) over 96 h. PMA treatment greatly reduced the numbers of cells entering S phase and also blocked cells exiting G2/M. The PMA-treated cells became adherent and expression of mature macrophage-specific genes increased progressively over the duration of the time course. Within 1-2 h PMA induced known targets of tumor protein p53 (TP53), notably , followed by gradual down-regulation of cell-cycle associated genes. Also within the first 2 h, PMA induced immediate early genes including transcription factor genes encoding proteins implicated in macrophage differentiation () and down-regulated genes for transcription factors involved in immature myeloid cell proliferation (). The dense time course revealed that the response to PMA was not linear and progressive. Rather, network-based clustering of the time course data highlighted a sequential cascade of transient up- and down-regulated expression of genes encoding feedback regulators, as well as transcription factors associated with macrophage differentiation and their inferred target genes. CAGE also identified known and candidate novel enhancers expressed in THP-1 cells and many novel inducible genes that currently lack functional annotation and/or had no previously known function in macrophages. The time course is available on the ZENBU platform allowing comparison to FANTOM4 and FANTOM5 data.

Citing Articles

Cell type-dependent directional transcription at enhancers.

Agrawal S, Kanamaru E, Saito Y, Ishikawa F, de Hoon M NAR Genom Bioinform. 2025; 7(1):lqaf007.

PMID: 40060372 PMC: 11886823. DOI: 10.1093/nargab/lqaf007.


The alternative polyadenylation regulator CFIm25 promotes macrophage differentiation and activates the NF-κB pathway.

Mukherjee S, Barua A, Wang L, Tian B, Moore C Cell Commun Signal. 2025; 23(1):115.

PMID: 40022203 PMC: 11871739. DOI: 10.1186/s12964-025-02114-1.


The relationship between extreme inter-individual variation in macrophage gene expression and genetic susceptibility to inflammatory bowel disease.

OBrien C, Summers K, Martin N, Carter-Cusack D, Yang Y, Barua R Hum Genet. 2024; 143(3):233-261.

PMID: 38421405 PMC: 11043138. DOI: 10.1007/s00439-024-02642-9.


Human CD34-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8 T cell and NK cell responses in vitro and in vivo.

van Eck van der Sluijs J, van Ens D, Brummelman J, Heister D, Sareen A, Truijen L Cell Mol Life Sci. 2023; 80(10):298.

PMID: 37728691 PMC: 10511603. DOI: 10.1007/s00018-023-04923-4.


The Bisdioxopiperazine ICRF-193 Attenuates LPS-induced IL-1β Secretion by Macrophages.

Brindle A, Bainbridge C, Kumar M, Todryk S, Padget K Inflammation. 2023; 47(1):84-98.

PMID: 37656316 PMC: 10798930. DOI: 10.1007/s10753-023-01895-2.


References
1.
Liu Z, Gu Y, Chakarov S, Bleriot C, Kwok I, Chen X . Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells. Cell. 2019; 178(6):1509-1525.e19. DOI: 10.1016/j.cell.2019.08.009. View

2.
Suhasini M, Reddy C, Reddy E, DiDonato J, Pilz R . cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation. Oncogene. 1997; 15(15):1859-70. DOI: 10.1038/sj.onc.1201530. View

3.
Garrison B, Rybak A, Beerman I, Heesters B, Mercier F, Scadden D . ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells. Blood. 2017; 130(5):619-624. PMC: 5542850. DOI: 10.1182/blood-2016-09-738591. View

4.
Crosslin D, McDavid A, Weston N, Zheng X, Hart E, de Andrade M . Genetic variation associated with circulating monocyte count in the eMERGE Network. Hum Mol Genet. 2013; 22(10):2119-27. PMC: 3633369. DOI: 10.1093/hmg/ddt010. View

5.
Laslo P, Spooner C, Warmflash A, Lancki D, Lee H, Sciammas R . Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell. 2006; 126(4):755-66. DOI: 10.1016/j.cell.2006.06.052. View